M M Hidalgo Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

1/2014

Dosing to rash: a phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M M Hidalgo Research Topics

Disease

1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2014
1	Exanthema (Rash) 01/2014
1	Aggressive Periodontitis (Periodontosis) 01/2001

Drug/Important Bio-Agent (IBA)

1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2014
1	Mitogen-Activated Protein KinasesIBA 01/2014
1	AntibodiesIBA 01/2001
1	leukotoxinIBA 01/2001